Long-term clinical outcomes of 538 prostate carcinoma patients treated with combination high-dose-rate brachytherapy and external beam radiotherapy
ConclusionCombined HDR-B/EBRT for the treatment of clinically localized prostate cancer provides superb clinical outcomes with excellent 5-year bRFS, dMFS, OS, and late GI/GU toxicity rates.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Carcinoma | External Beam Therapy | Gastroenterology | Hormonal Therapy | Hormones | Prostate Cancer | Toxicology